The trouble with developing an entirely new modality for treating deadly cancers of the head and trunk is that you're frequently explaining what you do and how you do it, but Novocure's tumor-treating electromagnetic fields may help patients with chemo-resistant tumors regain their lives.
When Novocure won FDA approval for its Tumor Targeting Field cancer therapy system, the company introduced the oncology world to an entire new modality for treatment.
Cancer patients today are most famliar with surgery, radiation and chemotherapy as thearpy optoins, but certain patients can also opt for Novocure's non-invasive electromagnetic therapy, which promises to stop cancer cells in their tracks without adding a new suite of side...
Rep. Bill Owens (D-N.Y.), an avid supporter of the Affordable Care Act, tells MassDevice.com why he decided this month to co-sponsor Rep. Erik Paulsen's (R-Minn.) medical device tax repeal bill.
Accuray CEO Euan Thomson discusses the finer points of robotic prostate cancer treatment and the motivation behind a head-to-head clinical trial pitting its CyberKnife radiosurgery system against Intuitive Surgical's da Vinci.
In an exclusive podcast interview with MassDevice.com, Rosa told us about the company's beginnings, his optimism for the still-sluggish heart failure treatment landscape and why it's so important that patients can disconnect from Sunshine Heart's flagship, outside-the-bloodstream C-Pulse heart assist device.
"In the U.S., for Class III heart failure there are about 1.5 million patients," Sunshine Heart CEO David Rosa told MassDevice.com in an exclusive podcast interview. "That's about 7 times the Class IV...
In his last interview as CEO of Philips Healthcare before taking the corner office at Quest Diagnostics, Steve Rusckowski tells MassDevice why 2011 was a tough year for the world's 7th-largest medical device maker, why things are looking up this year and how innovation can go hand-in-hand with lower costs.
It's not exactly news that the med-tech industry is under pressure from a variety of fronts – an uncertain regulatory environment, a looming tax burden and, not least, downward pricing pressure from its health care provider customers.
That last issue is particularly acute for medical device makers because their business model has long been anchored by developing high-ticket products and raising...
MassDevice discusses innovation, robotic surgery and Silicon Valley culture with Intuitive Surgical CEO Gary Guthart.